FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Par Sues FDA Over Colchicine Exclusivity Forfeiture

[ Price : $8.95]

Par Pharmaceutical files a lawsuit in DC federal court against FDA seeking reversal of an agency decision that revoked Pars eligib...

Lehigh Valley Tech Seeks Action Against Virtus Pharma

[ Price : $8.95]

Lehigh Valley Technologies petitions FDA asking it to take enforcement action against Virtus Pharmaceuticals Holdings and to remov...

Evoked Photon Image Capture Device into Class 1

[ Price : $8.95]

Federal Register Final Order: FDA classifies the Evoked Photon Image Capture Device into Class 1 (general controls).

FDA Amends Animal Drug Regs for Approvals, Etc.

[ Price : $8.95]

Federal Register Final Rule: FDA amends the animal drug regulations to reflect application-related actions for new animal drug app...

FDA Warns on Homeopathic Teething Products

[ Price : $8.95]

FDA warns that homeopathic teething tablets and gels may pose a risk to infants and children.

SEC Charges Ex-Puma Executive on Insider Trading

[ Price : $8.95]

The Securities and Exchange Commission charges the former senior director of regulatory affairs for Puma Biotechnology with inside...

FDA Sets Tropical Disease Voucher Fee at $2.7 Million

[ Price : $8.95]

Federal Register Notice: FDA announces the fee rate of $2.7 million for using a tropical disease priority review voucher for fisca...

Rare Pediatric Disease Priority Voucher Fee is $2.7 Million

[ Price : $8.95]

Federal Register Notice: FDA announces the fee rate of $2.7 million for using a rare pediatric disease priority review voucher for...

FDA Posts ICH Guidance on API GMPs

[ Price : $8.95]

FDA releases an International Conference on Harmonization guidance on Q7 Good Manufacturing Practice Guidance for Active Pharmaceu...

FDA Gives Breakthrough Status to AbbVie Hep C Therapy

[ Price : $8.95]

FDA grants AbbVie a breakthrough therapy designation for its investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibre...